Evommune (EVMN) Interest Expenses (2024 - 2026)
Evommune's (EVMN) quarterly Interest Expenses came in at $92.0 million in Q1 2026, up 45887.5% year-on-year from N/an in Q1 2025, and up 23503.31% on a QoQ basis from -$393000.0 in Q4 2025.
Evommune (EVMN) Interest Expenses (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Interest Expenses data on file, last reported at $92.0 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 45887.5% year-over-year to $92.0 million in Q1 2026; TTM through Mar 2026 was $92.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.5 million, up 6712.88% from the prior year.
- Interest Expenses for Q1 2026 stood at $92.0 million, up from -$393000.0 in the prior quarter.
- Over the last five years, Interest Expenses for EVMN reached as high as $92.0 million in Q1 2026 and fell as low as -$563000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $16.4 million across 3 years, with a median of $108500.0 in 2024.
- Across the five-year window, Interest Expenses surged 30.2% in 2025 and surged 45887.5% in 2026, its largest moves.
- Year by year, Interest Expenses stood at -$563000.0 in 2024, then soared by 30.2% to -$393000.0 in 2025, then soared by 23503.31% to $92.0 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $92.0 million in Q1 2026, -$393000.0 in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Evommune | 381.48 Mn | 170.02 Mn | - | 91.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.98 Mn |
| Mar 31, 2026 | 91.98 Mn |
| Dec 31, 2025 | -393,000.00 |
| Dec 31, 2025 | -393,000.00 |
| Sep 30, 2025 | 6.91 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -563,000.00 |
| Dec 31, 2024 | -563,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |